Skip to content

BEAURAING MEDICAL

Active
Private limited companyfounded 2003active for 23 yearsRue de Dinant 127, 5570 Beauraing, BelgiumKBO/BCE: BE 0479.984.110

From the official registers: KBO 23 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

BEAURAING MEDICAL has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €887,457 and a net result of €184,131. Equity has been growing by about 22% per year since 2018. Its solvency ranks better than 84% of 615 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

KBO
Status
Active since 09-04-2003 Normal situation
Activity
Research and development on biotechnology NACE 72101
Financial year end
31 December
Peppol
Reachable since 11-12-2025

Board and ownership

Board

Financial position

97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€259,573
▼ 6.5%
Turnover
≈ €520,000
estimated
Profit
€184,131
▼ 0.5%
Equity
€887,457
▲ 26.2%
Total assets
€977,534
▲ 19.4%
Staff
≈ 0 FTE
estimated
Filed on 19-05-2026, 73 days before the deadlinePDF
Score breakdownraises riskNo registered site in the KBOlowers riskSize: total assets €977,534Equity €887,457 (90.8% of total assets)Figures for financial year 2025 (filed on 19-05-2026)Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 72% of micro companies in research and development (NACE 72)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 90.8% of total assets
Liquidity 64-18
short-term debt 9.2% · cash 11.5%
Profitability 92-5
return on assets 18.8%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (935 companies, NACE 72, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025highest value 07-2025: < 0.1%▼ -0.1 percentage points vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: 0.1%▲ +0.1 percentage points vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €85,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 10.58 (6.81 in 2024), above the usual 1.5. Short-term debt is 9.2% and cash 11.5% of total assets. 9.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 83% of them on solvency, 54% on liquidity, 74% on profitability and 78% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €977,534
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €887,457 (90.8% of total assets)
NBB · annual accounts
raises risk · No registered site in the KBO
KBO · seat and establishments
lowers risk · Figures for financial year 2025 (filed on 19-05-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-05-2026, 73 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
73 days early
2024
35 days early
2023
51 days early
2022
73 days early
2021
23 days late
2020
20 days late
2019
80 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 38 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 11 June (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 91% of companies in research and developmentsector median €113,589 · 616 companies €887,457 View
  • Positive: Equity rose in 2025from €703,326 to €887,457 ▲ 26.2% View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

Comparable companies

These companies have the same main activity as BEAURAING MEDICAL: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €830,000 and €1.2m, founded between 2002 and 2006.

CompanyTotal assetsGross margin
BEAURAING MEDICAL Beauraing€1.0m€0.3m
AB PSY DINANT Dinant€1.0m€0.2m
DOKTER SCHOCKAERT Gent€0.8m€0.2m
HOUGARDY NICOLAS SRL Habay€1.2m€0.2m
Marco Guidi, geneesheer Dendermonde€1.0m€0.2m
Dokter Bernard Kint Antwerpen€1.1m€0.2m
NYEMB Tournai€1.2m€0.2m
Full comparison

Documents

Annual accounts at the NBB

All 23 annual accounts

Articles and registers

Key facts about BEAURAING MEDICAL

What is the company number of BEAURAING MEDICAL?
The company number of BEAURAING MEDICAL is 0479.984.110. The VAT number is the same number with BE in front: BE 0479.984.110.
Where is BEAURAING MEDICAL based?
The registered office is at Rue de Dinant 127, 5570 Beauraing.Company details
What does BEAURAING MEDICAL do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of BEAURAING MEDICAL?
The legal form of BEAURAING MEDICAL is Private limited company (BV).
When was BEAURAING MEDICAL founded?
BEAURAING MEDICAL was founded on 09-04-2003.
Is BEAURAING MEDICAL still active?
Yes, BEAURAING MEDICAL is an active enterprise in the KBO register.
What is the turnover of BEAURAING MEDICAL?
The turnover in financial year 2025 is ≈ €520,000. This figure is estimated from the gross margin of €259,573 and 881 comparable companies of the same size. It probably lies between €360,000 and €750,000. It is a rough estimate.Financials
Is BEAURAING MEDICAL profitable?
In financial year 2025, BEAURAING MEDICAL made a profit of €184,131.
Where can I find the annual accounts of BEAURAING MEDICAL?
BEAURAING MEDICAL filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of BEAURAING MEDICAL due?
BEAURAING MEDICAL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.